New oral drug shows promise for Hard-to-Control asthma
Disease control
Ongoing
This study tests an oral medication called dexpramipexole for people with eosinophilic asthma that is not well controlled by current treatments. About 600 participants will take the drug or a placebo daily for 24 weeks to see if it improves lung function, asthma control, and qual…
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC